MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Unlock precise diagnosis and personalized treatment for familial hypodysfibrinogenemia with genetic testing. Enhance family planning and expand mutation insights.
Explore how genetic testing aids in diagnosing familial hypoparathyroidism, enabling accurate diagnosis, personalized treatment, and informed family planning.
Uncover how genetic testing identifies ovarian cancer risks, guides prevention, and supports families. Explore BRCA1, BRCA2, and TP53's role in managing predispositions.
Explore how genetic testing aids in diagnosing Fatal Multiple Mitochondrial Dysfunctions Syndrome, focusing on IBA57 gene mutations, early intervention, and family planning.
Unlock the benefits of genetic testing for diagnosing and managing focal palmoplantar keratoderma, improving patient outcomes with personalized treatments.
Unlock insights on Frontotemporal Dementia using genetic testing. Explore diagnosis, disease severity, and personalized treatment strategies for improved outcomes.
Explore how genetic testing enhances ganglioglioma diagnosis and treatment, targeting BRAF mutations and MAP kinase pathway for improved patient outcomes.
Explore how genetic testing aids in early diagnosis and management of Glycogen Storage Disease Type IV, focusing on childhood neuromuscular forms and personalized care.